Efficacy was similar (ORR 53% versus 51%) regardless of whether ceritinib was administered immediately after crizotinib or not but there was a possible trend for a longer treatment duration in the case of ceritinib being administered immediately (4.2 months versus 3.3 months, respectively).
← all excerpts
Real-life experience of ceritinib in crizotinib-pretreated <i>ALK</i><sup>+</sup> advanced non-small cell lung cancer patients.
1
—
—